HEIH and endometrial cancer: Paclitaxel-mediated upregulation of HEIH in endometrial cancer cells as a possible mechanism for resistance, and HEIH silence restored chemo-sensitivity to paclitaxel by suppressing MAPK signaling pathway [41].